Caffeine
Appearance
| Clinical data | |
|---|---|
| AHFS/Drugs.com | monograph |
| Pregnancy category | |
| Dependence liability | Low–moderate[1] No addiction liability[1] |
| Routes o admeenistration | oral, insufflation, enema, rectal, intravenous |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 99% |
| Protein bindin | 25–36%[2] |
| Metabolism | Primarily CYP1A2;[2] Other enzymes: CYP2E1, CYP2C8, CYP2C9, CYP3A4[2] |
| Biological hauf-life | Adults: 3–7 hours[2] Neonates: 65–130 hours[2] |
| Excretion | urine (100%) |
| Identifiers | |
| |
| Synonyms | Methyltheobromine |
| CAS Nummer | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| PDB ligand | |
| ECHA InfoCard | 100.000.329 |
| Chemical and physical data | |
| Formula | C8H10N4O2 |
| Molar mass | 194.19 g/mol |
| 3D model (Jmol) | |
| Density | 1.23 g/cm3 |
| Meltin pynt | 235 tae 238 °C (455 tae 460 °F) (anhydrous) |
| Bylin pynt | 178 °C (352 °F) (sublimes) |
| |
| |
Caffeine (/kæˈfiːn, ˈkæfiːn, ˈkæfiːɪn/) is a bitter, white crystalline xanthine alkaloid an a stimulant drug.
References
[eedit | eedit soorce]- ↑ a b Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 15: Reinforcement and Addictive Disorders". In Sydor A, Brown RY (ed.). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. p. 375. ISBN 9780071481274.
Long-term caffeine use can lead to mild physical dependence. A withdrawal syndrome characterized by drowsiness, irritability, and headache typically lasts no longer than a day. True compulsive use of caffeine has not been documented.
CS1 maint: multiple names: authors leet (link) - ↑ a b c d e "Caffeine". DrugBank. University of Alberta. 16 September 2013. Retrieved 8 August 2014.
|section=ignored (help)